Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

View source ↗

Summary

This update reports results from an observational study of Tarceva (erlotinib) in elderly patients with advanced non-small cell lung cancer; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Squamous Non-Small Cell Lung Cancer | Status: COMPLETED | Results posted: 2015-10-29